Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
New leader to continue to drive long-term innovation in Novartis research in wide range of therapeutic areas Basel, September 24, 2015 - Novartis announced today that Dr. James (Jay) E....
-
DGAP-News: PAION AG / Key word(s): Change of Personnel JUERGEN RATHS, MD APPOINTED AS CHIEF OPERATING OFFICER AT PAION AG 27.08.2015 /...
-
30 July 2015 H1 2015 Results Financial Summary +---------------------+------+----+------++-----+----+------+ | |H1 2015 ||Q2 2015 ...
-
Company Reports Preliminary Second Quarter 2015 Total Net Product Sales of Between $63 and $64 Million and Preliminary Cash and Cash Equivalents of Approximately $82 Million as of June 30,...
-
WAYNE, Pa., July 23, 2015 (GLOBE NEWSWIRE) -- via PRWEB - Safeguard Scientifics, Inc. (NYSE:SFE) today announced second quarter 2015 financial results. Safeguard's partner companies achieved...
-
CAMBRIDGE, Mass., July 13, 2015 (GLOBE NEWSWIRE) -- CoLucid Pharmaceuticals, Inc. (Nasdaq:CLCD), a Phase 3 clinical-stage biopharmaceutical company that is developing its lead product candidate,...
-
COLUMBUS, Ind., June 30, 2015 (GLOBE NEWSWIRE) -- Cummins Inc. (NYSE: CMI) today announced that Dr. John Wall, Vice President – Chief Technical Officer, will be retiring after nearly 30 years...
-
CAMBRIDGE, Mass., June 25, 2015 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies...
-
Collaboration Combines bluebird bio's Gene Editing and Lentiviral Gene Delivery Technologies and Kite's TCR Capabilities and Exclusive Rights to a TCR Directed Against the HPV-16 E6...
-
CAMBRIDGE, Mass., June 16, 2015 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies...